BPA for sohonos
Active Awarded Last action
- Contract number
- 36E79724A0012
- Awardee
-
Ipsen Biopharmaceuticals Inc. UEI YJTQU9382HU5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 86% complete
- IDV ceiling
- $535,300.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA) for SOHONOS was awarded as a single-award contract to Ipsen Biopharmaceuticals Inc. (doing business as Tercica Inc.) by the National Acquisition Center, a civilian federal agency. The contract was awarded on April 3, 2024, with a ceiling value of $535,300.00 and an ultimate completion date of April 2, 2027. The BPA operates under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), indicating that the contractor will provide pharmaceutical products and drug-related services under established pricing and terms. This represents an exercise of Option Year 2 of BPA 36E79724A0012, demonstrating the continuation of an existing contractual relationship rather than a new procurement action.
As a single-award BPA with no set-asides applied, this contract provides the National Acquisition Center with access to Ipsen Biopharmaceuticals Inc.'s pharmaceutical offerings through a mechanism that allows for streamlined ordering and delivery of products and services as needed throughout the contract period. The use of a GSA Schedule BPA framework ensures compliance with federal procurement regulations while enabling flexibility in quantities and delivery schedules. The vendor's UEI is YJTQU9382HU5, and ordering activities under this BPA will proceed according to established GSA Schedule pricing and terms unless modified through specific task orders or delivery orders issued during the contract performance period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0012?
36E79724A0012 was awarded to Ipsen Biopharmaceuticals Inc. by National Acquisition Center (Headquarters) on April 3, 2024.
How much is contract 36E79724A0012 worth?
36E79724A0012's own ceiling is $535,300.
Who can order from contract 36E79724A0012?
36E79724A0012 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0012 under another contract?
Yes. 36E79724A0012 is a blanket purchase agreement under 36F79718D0422, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79724A0012 competed?
The extent of competition for 36E79724A0012 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV